Navigation Links
I3, the Developer of Innovative Infusion Therapy Solutions, to Present at Medtech Insight In3 Conference in Las Vegas, March 4-5, 2010
Date:2/23/2010

LA JOLLA, Calif., Feb. 23 /PRNewswire/ -- I3 Corporation announced today that the Company will be presenting on its lead product, the Q-FLO™ closed system, as a superior alternative to conventional closed systems for medication transport and delivery, at the In3 West Conference on March 4-5, 2010, at the Venetian Resort in Las Vegas, NV.

The Q-FLO™ is I3's lead product that encompasses a male and female luer lock mechanism for closed system medication transport and delivery.  The Q-FLO™ offers unique features and benefits for medication delivery, which include: a) a closed, no drop, valved connection system preventing drips and spillage of cytotoxic drugs, b) convenient locking mechanism allowing for a fast and easy mechanism to establish a patent connection; c) Passive 'Fool Proof' Safety System which seals off upon disconnection to help prevent exposure to hazardous compounds; d) first ever Visual Indicator that provides for a clear, color coded, visual confirmation of the status of the connection; e) the lowest internal residual volume of any closed system on the market; f) rotational actuation, which allows for a pumping action within the male luer connector offering the flexibility of creating a negative, positive, or neutral bolus effect, and finally g) safe material composition, which is entirely Latex, DEHP, and Silicon-free, making the Q-FLO™ an ideal connector system for the entire spectrum of chemotherapy and nuclear medicine drugs.

"The Q-FLO™ represents a significant advance in the state of the art of closed system devices, offering improved safety and convenience for healthcare workers administering cytotoxic drugs to patients around the world," stated Babak Nemati, Ph.D., President & CEO of I3.  "We are proud of the accomplishments of our design and development team, and we look forward to the commercial launch of this important product line with our distribution partners later this year."

In the current hospital environment, thousands of pharmacists, nurses, physicians and other caregivers may encounter a serious threat to their own physical and reproductive health, on a daily basis, through inadvertent exposure to cytotoxic drugs, such as chemotherapy, antivirals, antibiotics, hormones, nuclear medicine drugs.  The US federal government estimates that 5.5 million healthcare workers continue to be exposed to these substances each year.  Advances in closed systems such as the I3 Q-FLO™ offer the promise of creating a safe working environment for healthcare providers worldwide.

About I3 Corporation (www.infusioninnovations.net)

I3 is a La Jolla, California, based emerging medical device company focused on the design and development of innovative products for improved safety of the hospital environment.  Founded in 2006, I3 has a strong proprietary portfolio of products ranging from needle-less injection site connectors, to safety syringes, and bio-diagnostic sampling devices.  The fundamental driving philosophy behind our products is bringing key engineering innovation to improve safety, ease of use, and functionality of established hospital based products.

For more information, please contact us at info@infusioninnovations.net.

SOURCE I3 Corporation

Back to top

RELATED LINKS
http://www.infusioninnovations.net

'/>"/>

SOURCE I3 Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
2. Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Marylands Emerging Company of the Year Award
3. Malaria Vaccine Developer, Sanaria Inc., Receives 2009 Vaccine Industry Excellence Award for Best Early-Stage Vaccine Biotech
4. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference
7. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
8. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
9. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
10. Innovative Brain Scanning for Alzheimers Screening Unveiled
11. Gates Foundation Seeks Proposals for Innovative Global Health Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , May 24, 2016 ... doble terapia del mundo, introduce catéteres para la ... OrbusNeich, una compañía global especializada en el ... ha expandido su cartera incluyendo productos para tratar ... y Scoreflex™ PTA son los dispositivos de primera ...
(Date:5/23/2016)... May 23, 2016 According ... Equipment Market by Product (Wheelchair, Scooters, Medical Beds, ... Care, Critical Care, Wound), Accessories (Lifting, Transfer) & ... 2021", published by MarketsandMarkets, the patient handling equipment ... by 2021 at a CAGR of 10.5% during ...
(Date:5/23/2016)... 2016 Clarifying Vision - Prospects ... and Vision Care What can be expected ... to grow at the fastest rates? This visiongain ... data, trends, opportunities and prospects. ,Our ... the most lucrative areas in the industry and the ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... ... Cheryl Bowker of Bowker Insurance Group has been presented with one of ... McKenna ran one of Allstate’s most successful agencies for 48 years, but it was ... The award named for him is not given every year, but only when an ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... solutions to industries ranging from medical and pharmaceutical, to food and HVAC facilities. ... well as on-site training. , For medical applications, Afrimesure offers a variety ...
(Date:5/25/2016)... ... May 25, 2016 , ... Conrad Siegel Actuaries, delivering comprehensive ... Prescription Drug survey , an employee benefits survey measuring how Central ... December 2015, indicates that employers are turning to consumer directed health care and ...
(Date:5/25/2016)... ... ... than fifty years, we've suffered whiplash as each new scientific study seemed to contradict the ... advice – advice that was supposed to keep us healthy and slim. And what happened? ... considered to be overweight and more than 1 in 3 adults are considered to be ...
(Date:5/25/2016)... ... May 25, 2016 , ... BeniComp ... a significant spike in their clients' employee participation for their wellness initiatives. ... by implementing a high-deductible health plan with outcome-based deductible incentives. As a result, ...
Breaking Medicine News(10 mins):